Jason Benjamin Van Pelt is named as a lobbyist on federal disclosure filings for 41 clients through Crossroads Strategies, LLC. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PROTON THERAPY CONSORTIUM | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid |
| COUPANG, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Economics/Economic Development, Trade (domestic/foreign) |
| LATHAM & WATKINS LLP OBO PEDIATRIC ASSOCIATES | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid |
| BROAD INSTITUTE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Science/Technology, Defense, Medical/Disease Research/Clinical Labs |
| 3M COMPANY | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Environment/Superfund, Consumer Issues/Safety/Products |
| TRANSAMERICA COMPANIES | CROSSROADS STRATEGIES, LLC | Q3 2026 | Financial Institutions/Investments/Securities, Homeland Security |
| SPIDER STRATEGIES, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Defense |
| SANOFI US SERVICES INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| PRECISION MOTION HEALTH | CROSSROADS STRATEGIES, LLC | Q3 2026 | Labor Issues/Antitrust/Workplace |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| MADRIGAL PHARMACEUTICALS, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| HALEON US HOLDINGS LLC | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| EPILEPSY FOUNDATION OF AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code, Health Issues |
| CENTERSTONE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| BLOOD CANCER UNITED, INC. (FKA LEUKEMIA & LYMPHOMA SOCIETY, INC. (LLS) | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid |
| BLINK HEALTH, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Pharmacy |
| AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| ALKERMES, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Pharmacy |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| VERTEX PHARMACEUTICALS INCORPORATED | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| RESEARCH!AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Science/Technology, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| MERCK & CO., INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| KLASKO IMMIGRATION LAW PARTNERS, LLP ON BEHALF OF INTEALTH | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues, Homeland Security, Immigration |
| KIDNEY CARE PARTNERS | CROSSROADS STRATEGIES, LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| EISAI, INC. | CROSSROADS STRATEGIES, LLC | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| CONCORDANT LLC OBO AMERICANS GIVE LLC | CROSSROADS STRATEGIES, LLC | Q3 2026 | Taxation/Internal Revenue Code |
| ATLANTIC DIVING SUPPLY, INC. (ADS) | CROSSROADS STRATEGIES, LLC | Q3 2026 | Defense |
| ATKINSREALIS NUCLEAR SECURED, LLC | CROSSROADS STRATEGIES, LLC | Q3 2026 | Energy/Nuclear |
| FOUNTAIN HOUSE | CROSSROADS STRATEGIES, LLC | Q3 2026 | Health Issues |
| BRISTOL-MYERS SQUIBB | CROSSROADS STRATEGIES, LLC | Q4 2025 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| APNIMED, INC. | CROSSROADS STRATEGIES, LLC | Q4 2025 | Medicare/Medicaid |
| GENERAL ATOMICS | CROSSROADS STRATEGIES, LLC | Q3 2025 | Energy/Nuclear |
| ADVOCATES FOR COMMUNITY HEALTH | CROSSROADS STRATEGIES, LLC | Q3 2025 | Health Issues |
| THE BOEING COMPANY | CROSSROADS STRATEGIES, LLC | Q3 2025 | Health Issues |
| INDIVIOR INC. | CROSSROADS STRATEGIES, LLC | Q3 2025 | Medicare/Medicaid, Pharmacy |
| COALITION FOR 1099-K FAIRNESS | CROSSROADS STRATEGIES, LLC | Q3 2025 | Taxation/Internal Revenue Code |
| VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG | CROSSROADS STRATEGIES, LLC | Q2 2025 | Medicare/Medicaid, Health Issues |
| NOVAVAX, INC. | CROSSROADS STRATEGIES, LLC | Q2 2025 | Trade (domestic/foreign), Health Issues, Budget/Appropriations |
| LIFESCIENCE LOGISTICS | CROSSROADS STRATEGIES, LLC | Q1 2025 | Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 31 | 1 |
| 2025 | 30 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 9 | $8K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Jason Benjamin Van Pelt. See the Capitol Clarity rankings and method.